相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study
Felix Mahfoud et al.
CIRCULATION (2011)
Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults
Elisabeth Lambert et al.
HYPERTENSION (2010)
Sex, Menopause, Metabolic Syndrome, and All-Cause and Cause-Specific Mortality-Cohort Analysis from the Third National Health and Nutrition Examination Survey
Jou-Wei Lin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Increased Sympathetic and Decreased Parasympathetic Activity Rather Than Changes in Hypothalamic-Pituitary-Adrenal Axis Activity Is Associated with Metabolic Abnormalities
Carmilla M. M. Licht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
W. Philip T. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sympathetic nervous activation in obesity and the metabolic syndrome-Causes, consequences and therapeutic implications
Gavin W. Lambert et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Cardiovascular and Renal Complications of Type 2 Diabetes in Obesity: Role of Sympathetic Nerve Activity and Insulin Resistance
Kazuko Masuo et al.
CURRENT DIABETES REVIEWS (2010)
Blood pressure control and components of the metabolic syndrome: the GOOD survey
Walter Zidek et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Elevated Heart Rate in Cardiovascular Diseases: A Target for Treatment?
Paolo Palatini
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Menopause and the metabolic syndrome - The Study of Women's Health Across the Nation
Imke Janssen et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Metabolic Syndrome Affects Cardiovascular Risk Profile and Response to Treatment in Hypertensive Postmenopausal Women
Rosario Rossi et al.
HYPERTENSION (2008)
Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women
Maritta K. Poyhonen-Alho et al.
JOURNAL OF HYPERTENSION (2008)
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey
Sverre E. Kjeldsen et al.
JOURNAL OF HYPERTENSION (2008)
Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
H. Ebinc et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)
Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women
Gerald B. Phillips et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Resting heart rate in cardiovascular disease
Kim Fox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The sympathetic nervous system and the metabolic syndrome
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Renin-angiotensin system and cardiovascular risk
Roland E. Schmieder et al.
LANCET (2007)
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial
Giuseppe Derosa et al.
CLINICAL THERAPEUTICS (2007)
Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin
Irina Chazova et al.
DIABETES OBESITY & METABOLISM (2006)
Selective imidazoline agonist moxonidine in obese hypertensive patients
AF Sanjuliani et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Gender differences in the metabolic syndrome and their role for cardiovascular disease
V Regitz-Zagrosek et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study
AM Sharma et al.
JOURNAL OF HUMAN HYPERTENSION (2004)
分享论文
